ITRM vs MAS · rev $390.0K vs P/E 18, rev $7.83B
Iterum Therapeutics PLC (ITRM) versus Masco Corporation (MAS) — a side-by-side from cached financials, not a winner call.
Iterum Therapeutics PLC (ITRM) is a biotechnology company listed on US.
Masco Corporation (MAS) is a building products & equipment company listed on US.
Latest reported ITRM revenue for 2025-09-30 was $390.0K. Net income was -$20.4M. ITRM currently screens at market cap $38.6M.
Latest reported MAS revenue for 2024-12-31 was $7.83B. Net income was $874.0M. Revenue was down 1.7% from 2023-12-31 to 2024-12-31. MAS currently screens at market cap $14.00B and trailing P/E 18.1.
ITRM currently screens at market cap $38.6M. MAS currently screens at market cap $14.00B and trailing P/E 18.1.
Not investment advice. Open the ITRM and MAS stock pages for the full models.
Not investment advice.